NCT03571412

Brief Summary

This study evaluates the efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) over Left Dorsolateral Prefrontal Cortex and Dorsomedial Prefrontal Cortex on Major Depressive Disorder (MDD).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable major-depressive-disorder

Timeline
Completed

Started Aug 2016

Shorter than P25 for not_applicable major-depressive-disorder

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 27, 2018

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

12 months

First QC Date

January 10, 2018

Last Update Submit

April 15, 2019

Conditions

Keywords

DepressionMajor Depressive Disorder

Outcome Measures

Primary Outcomes (1)

  • Changes in depressive symptoms evaluated by Hamilton Depressive Rating Scale (HADRS)

    Hamilton Depressive Rating Scale (HADRS) is a 21 item clinimetric scale to evaluate severity of depressive symptoms in patients.

    3 weeks

Secondary Outcomes (1)

  • Changes in depressive symptoms evaluated by Montgomery-Asberg Depressive Rating Scale (MADRS)

    3 weeks

Study Arms (2)

5Hz Left Dorsolateral Prefrontal Cortex

EXPERIMENTAL

This group will receive 5Hz Left Dorsolateral Prefrontal Cortex repetitive Transcranial Magnetic Stimulation. Once a day on monday to friday. Until complete 15 sessions.After complete acute phase intervention (15 sessions) subject will have a 5 week clinical follow up.

Device: repetitive Transcranial Magnetic Stimulation

5Hz Dorsomedial Prefrontal Cortex

EXPERIMENTAL

This group will receive 5Hz Dorsomedial Prefrontal Cortex Transcranial Magnetic Stimulation, once a day on monday to friday. Until complete 15 sessions.After complete acute phase intervention (15 sessions) subject will have a 5 week clinical follow up.

Device: repetitive Transcranial Magnetic Stimulation

Interventions

Subject will receive 5Hz LDLPFC or 5Hz DMPFC rTMS

Also known as: Transcranial Magnetic Stimulation
5Hz Dorsomedial Prefrontal Cortex5Hz Left Dorsolateral Prefrontal Cortex

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old.
  • Meet DSM 5 (Diagnostic and Statistical Manual, 5 edition) diagnostic criteria for Major Depressive Disorder.
  • Score \>17 in Hamilton Depression Rating Scale.

You may not qualify if:

  • Subjects with diagnose of Psychotic Depression, Schizophrenia, Bipolar Disorder, Post Traumatic Stress Disorder.
  • Subjects with epilepsy or presence of paroxysms during the EEG.
  • Subjects with previous history of traumatic brain injury, metal plates in the skull, cochlear devices, infusion devices such as insulin pumps.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Julian Reyes, PhD

    Universidad Autónoma de Querétaro

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The purpose to this study is to valuate the clinical effects of 5Hz rTMS over Left Dorsolateral Prefrontal Cortex and Dorsomedial Prefrontal Cortex
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 10, 2018

First Posted

June 27, 2018

Study Start

August 8, 2016

Primary Completion

July 31, 2017

Study Completion

September 1, 2017

Last Updated

April 16, 2019

Record last verified: 2019-04